Latest filing published 11 Aug 2026 for Boston Scientific CORP, €433k.
All filings by Jonathan Monson on record concern Boston Scientific Corp, in the capacity of senior executive. Between 1 December 2019 and 10 August 2026, the trades on record add up to 50 filings.
Sales make up the whole of the open-market record (3 sales, €771k). Other entries cover 13 share grants and 33 option exercises.
Most recently, on 11 August 2026, the filings show a transaction worth €433k in Boston Scientific Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 50 declarations